This vulnerability stemmed not only from poorly controlled baseline kidney function but also from heightened inflammatory and dysregulated immune responses characteristic of hypertensive individuals, potentially mediated by endothelial dysfunction and alterations in angiotensin-converting enzyme 2 (ACE2) expression[18,19]. This evidence concerns the gene ACE2 and endothelial dysfunction.